Skip to main content
Signal8
Douglass Brian Robb profile photo

Brian Robb Douglass

CIK: 0002104618

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REPLIGEN CORP logo
RGEN

REPLIGEN CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • REPLIGEN CORP logo
    RGEN

    REPLIGEN CORP

    Oct 6, 2026
    Award(A)
    Direct
    700 shares-
  • REPLIGEN CORP logo
    RGEN

    REPLIGEN CORP

    May 7, 2026
    Tax Payment(F)
    Direct
    334 shares at avg. $126.43$42K
  • REPLIGEN CORP logo
    RGEN

    REPLIGEN CORP

    Mar 2, 2026
    Tax Payment(F)
    Direct
    221 shares at avg. $124.97$28K
  • REPLIGEN CORP logo
    RGEN

    REPLIGEN CORP

    Dec 31, 2025
    Award(A)
    Direct
    2.3K shares-

1-4 of 4

About Douglass Brian Robb

Douglass Brian Robb (SEC CIK 0002104618) files insider reports with the SEC as CHIEF PRODUCT OFFICER of REPLIGEN CORP (RGEN).

Signal8 holds 5 ownership filings by Douglass Brian Robb (1 Form 3, 4 Form 4), filed between Jan 12, 2026 and Oct 8, 2026. Those filings report 4 transactions, from Dec 31, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Douglass Brian Robb's filings is in WALTHAM, MA.

Recent filings by Douglass Brian Robb

  • Oct 6, 2026: Grant or award of RGEN shares (Form 4, code A).
  • May 7, 2026: Tax withholding of RGEN shares (Form 4, code F).
  • Mar 2, 2026: Tax withholding of RGEN shares (Form 4, code F).
  • Dec 31, 2025: Grant or award of RGEN shares (Form 4, code A).

Other insiders filing for REPLIGEN CORP (RGEN)

How to read Form 4 transaction codes